BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23201483)

  • 1. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
    J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates.
    Fehlberg LC; Andrade LH; Assis DM; Pereira RH; Gales AC; Marques EA
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):126-8. PubMed ID: 23891221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
    Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
    J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
    Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
    J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.
    Vicenzi FJ; Pillonetto M; Souza HA; Palmeiro JK; Riedi CA; Rosario-Filho NA; Dalla-Costa LM
    Mem Inst Oswaldo Cruz; 2016 Jan; 111(1):37-42. PubMed ID: 26814642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of different molecular and phenotypic methods for identification of environmental Burkholderia cepacia complex.
    Furlan JPR; Pitondo-Silva A; Braz VS; Gallo IFL; Stehling EG
    World J Microbiol Biotechnol; 2019 Feb; 35(3):39. PubMed ID: 30739255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing the Cut-off Score Value of MALDI-ToF MS Increase the Identities of Burkholderia cepacia Complex Species.
    Vianna EF; Pentagna LSDS; Menezes NIM; de Freitas FAD; Leite CDCF; Albano RM; Leão RS; Marques EA
    Curr Microbiol; 2021 Jun; 78(6):2259-2263. PubMed ID: 33944984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia complex: 11 years of surveillance in patients with Cystic Fibrosis in Posadas, Argentina.
    Martina PF; Martinez M; Rivas S; Leguizamón L; Von Specht M; Ferreras J
    Rev Argent Microbiol; 2020; 52(3):176-182. PubMed ID: 31879049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.
    Abbott FK; Milne KE; Stead DA; Gould IM
    Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of
    Wong KSK; Dhaliwal S; Bilawka J; Srigley JA; Champagne S; Romney MG; Tilley P; Sadarangani M; Zlosnik JEA; Chilvers MA
    J Med Microbiol; 2020 Aug; 69(8):1105-1113. PubMed ID: 32597748
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L
    New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development and evaluation of an in-house database for quick identification of Burkholderia contaminans by MALDI-TOF MS].
    Cipolla L; Rocca F; Armitano RI; Martinez C; Almuzara M; Faccone D; Vay C; Prieto M
    Rev Argent Microbiol; 2019; 51(3):255-258. PubMed ID: 30558855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal diversity among Burkholderia cepacia complex isolates from cystic fibrosis patients in a reference unit.
    Barrado L; Martinez MT; Villa J; Orellana MÁ; Viedma E; Chaves F
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):665-8. PubMed ID: 23850187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.